| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2007 | EP1746982A2 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases |
| 01/31/2007 | EP1746981A2 Medicinal aerosol formulation products with improved chemical stability |
| 01/31/2007 | EP1746975A2 Delayed release formulations of 6-mercaptopurine |
| 01/31/2007 | EP1746974A2 Rapid setting calcium phosphate cements |
| 01/31/2007 | EP1746971A1 Dermatological composition for the treatment of pigmentary disorders of the skin |
| 01/31/2007 | EP1746894A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake |
| 01/31/2007 | EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 01/31/2007 | EP1746885A1 Agonists of a2a adenosine receptors for treatment of diabetic nephropathy |
| 01/31/2007 | EP1746884A2 Stabilized hyaluronan preparations and related methods |
| 01/31/2007 | EP1746882A2 Methods for treating blood disorders with nitric oxide donor compounds |
| 01/31/2007 | EP1641448A4 Mixed zeaxanthin ester concentrate and uses thereof |
| 01/31/2007 | EP1587801B1 A process for preparing duloxetine and intermediates for use therein |
| 01/31/2007 | EP1572182B1 Composition for the treatment of gastrointestinal disorders |
| 01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1365749B1 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 01/31/2007 | EP1320373B1 Treatment of arthritis and compositions therefore |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | EP1052999B1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions |
| 01/31/2007 | EP1011689B1 USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS |
| 01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/31/2007 | CN1906308A Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use |
| 01/31/2007 | CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906207A Di-steroidal prodrugs of ethinyl estradiol |
| 01/31/2007 | CN1906206A Di-steroidal prodrugs of estradiol |
| 01/31/2007 | CN1906203A Glycosaminoglycan (GAG) mimetics |
| 01/31/2007 | CN1906201A Methods of preparing olanzapine |
| 01/31/2007 | CN1906200A Novel compounds |
| 01/31/2007 | CN1906199A Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 01/31/2007 | CN1906196A 4'-substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity |
| 01/31/2007 | CN1906194A Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon |
| 01/31/2007 | CN1906192A Hydroxylamine substituted imidazo ring compounds |
| 01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
| 01/31/2007 | CN1906189A 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders |
| 01/31/2007 | CN1906188A Phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as IGF-1R inhibitors |
| 01/31/2007 | CN1906187A 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1906182A Nitrooxyderivatives of antihypertensive drugs |
| 01/31/2007 | CN1906180A New long acting beta-2-agonists and their use as medicaments |
| 01/31/2007 | CN1906178A 喹唑啉衍生物 Quinazoline derivatives |
| 01/31/2007 | CN1906176A Therapeutic agents II |
| 01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/31/2007 | CN1906172A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 01/31/2007 | CN1906170A 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics |
| 01/31/2007 | CN1906169A Therapeutic agents I |
| 01/31/2007 | CN1906168A Methods and compositions for selectin inhibition |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1906164A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 01/31/2007 | CN1906163A 4-phenylpiperidine derivatives as renin inhibitors |
| 01/31/2007 | CN1906162A Hydroxy piperidine derivatives to treat gaucher disease |
| 01/31/2007 | CN1906160A Imidazole derivatives, processes for preparing them and their uses |
| 01/31/2007 | CN1906159A Prostaglandin nitrooxyderivatives |
| 01/31/2007 | CN1906154A Aminoalcohol derivatives |
| 01/31/2007 | CN1906149A Higher fullerenes useful as radical scavengers |
| 01/31/2007 | CN1906126A High-efficiency fullerene-based radical scavengers |
| 01/31/2007 | CN1905906A A lock solution for medical devices |
| 01/31/2007 | CN1905902A Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases |
| 01/31/2007 | CN1905901A Erythrocyte function modifying substance |
| 01/31/2007 | CN1905896A Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 01/31/2007 | CN1905891A Methods and compositions for the treatment of skin changes associated with aging and environmental damage |
| 01/31/2007 | CN1905888A Element sulfur as an oral or parental medical product |
| 01/31/2007 | CN1905887A Myocardial persufion imaging using adenosine receptor agonists |
| 01/31/2007 | CN1905886A A composition containing ginsenoside F1 or compound K for skin external application |
| 01/31/2007 | CN1905885A Extended use combination comprising estrogens and progestins |
| 01/31/2007 | CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases |
| 01/31/2007 | CN1905883A New derivatives of 6-4{4-[1h-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one |
| 01/31/2007 | CN1905882A Vascular intimal hyperplasia inhibitor |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/31/2007 | CN1905880A Compositions comprising organic compounds |
| 01/31/2007 | CN1905879A Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist |
| 01/31/2007 | CN1905878A Compounds for the sustained reduction of body weight |
| 01/31/2007 | CN1905877A Pharmaceutical composition for promoting angiogenesis |
| 01/31/2007 | CN1905876A Use of dipeptidyl peptidase IV inhibitors |
| 01/31/2007 | CN1905875A The use of quaternary pyridinium salts as vasoprotective agents |
| 01/31/2007 | CN1905874A Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 01/31/2007 | CN1905871A N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methansulfonic acid salt |
| 01/31/2007 | CN1905870A Methods and reagents for the treatment of inflammatory disorders |
| 01/31/2007 | CN1905869A Indolinone based protein kinase inhibitors |
| 01/31/2007 | CN1905868A DPP-IV inhibitors |
| 01/31/2007 | CN1905867A Facially amphilic polymers and oligomers and uses thereof |
| 01/31/2007 | CN1905866A Tulobuterol adhesive patch |
| 01/31/2007 | CN1905865A Combination drug therapy to treat obesity |
| 01/31/2007 | CN1905864A DNA damage repair inhibitors for treatment of cancer |
| 01/31/2007 | CN1905863A Methods and compositions for the treatment of metabolic disorders |
| 01/31/2007 | CN1905860A Phosphodiesterase V inhibitor formulations |
| 01/31/2007 | CN1905857A Controlled release of topiramate in liquid dosage forms |
| 01/31/2007 | CN1905856A Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 01/31/2007 | CN1905810A Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 01/31/2007 | CN1904900A Human autogenous siRNA sequence, its application and screening method |
| 01/31/2007 | CN1904158A Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
| 01/31/2007 | CN1904059A Production method of konjak mannose using cellulase |
| 01/31/2007 | CN1903915A Cationic emulsion composition of high polymeric organosiloxane and preparation thereof |
| 01/31/2007 | CN1903911A Polyether glucoside ester large molecule compound and its preparation method |